Konan, Japan

Shigeru Ueki

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 1999-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Ueki. Retrieved from https://idiyas.com/inventor/shigeru-ueki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1999-2004

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shigeru Ueki: Innovator in Pharmaceutical Patents

Introduction

Shigeru Ueki is a notable inventor based in Konan, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of remedies for colonic motor dysfunction. With a total of 3 patents to his name, Ueki's work has the potential to impact many lives.

Latest Patents

Ueki's latest patents include innovative formulations such as "Colonic motor dysfunction remedies comprising aminothiazole derivatives as active ingredients" and "Substituted benzoylaminothiazole derivatives and drugs containing the." These patents reflect his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Shigeru Ueki is currently associated with Zeria Pharmaceutical Co., Ltd., a company known for its dedication to pharmaceutical research and development. His work at Zeria has allowed him to focus on creating effective treatments that address specific health issues.

Collaborations

Ueki has collaborated with esteemed colleagues such as Masaaki Nagasawa and Hiroyasu Nishioka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Shigeru Ueki's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…